Home » Studies
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease linked to diabetes and obesity. Many people with NASH don’t even know they have it. Over time, NASH can lead to fibrosis (scarring) of the liver and permanent liver damage. There are currently no approved treatments for NASH, so clinical research studies are essential to finding treatment options for people living with NASH.
The study will evaluate whether an oral investigational medication called elafibranor is safe and effective in treating and preventing disease progression in patients who have NASH with fibrosis.
To learn more or to see if you may qualify for the study, UH contact: Stephanie at 021 957 9400
This practice is dedicated to providing care of the highest ethical and medical standards. Our approach is one of careful and thorough assessment with the aim of problem-solving. We also aim to empower our clients with knowledge to better understand and manage their condition.